Jefferies Financial Group
STLN icon

Jefferies Financial Group’s Starling Oncology STLN Stock Holding History

Jefferies Financial Group’s Portfolio STLN Stock Details STLN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$110K Buy
+17,445
New +$104K ﹤0.01% 1172
2023
Q1 		– Sell
-192,452
Closed -$318K – 1990
2022
Q4 		$318K Buy
+192,452
New +$540K ﹤0.01% 1188

Other funds holding STLN

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Creative Planning
Creative Planning Overland Park, Kansas $179B AUM 16.96% 1-Year Est. Return
Kingswood Wealth Advisors
Kingswood Wealth Advisors San Diego, California $2.6B AUM 27.46% 1-Year Est. Return
State of Wyoming
State of Wyoming Cheyenne, Wyoming $1.29B AUM 32.25% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return
T3 Companies
T3 Companies New York $103M AUM 54.73% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $64.1B AUM 28.9% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $500B AUM 36.84% 1-Year Est. Return

Jefferies Financial Group's STLN Position: Q3 2026 in Review

Jefferies Financial Group opened a new position in Starling Oncology (STLN) in Q3 2026: 17,445 shares worth $110K. The stake represents ﹤0.01% of the portfolio and ranks #1172 among its holdings. This is a return to the name: Jefferies Financial Group previously reported a position in STLN as recently as Q4 2022.

Jefferies Financial Group first reported a position in STLN in Q4 2022 and has held it in 2 quarters since. The position peaked at $318K in Q4 2022. 37 funds tracked by Wall St. Rank hold STLN as of Q3 2026.

  • Jefferies Financial Group held 17,445 shares of Starling Oncology worth $110K as of Q3 2026.
  • Starling Oncology was a new Jefferies Financial Group position in Q3 2026.
  • Starling Oncology made up ﹤0.01% of Jefferies Financial Group's portfolio in Q3 2026, its #1172 holding.
  • Jefferies Financial Group first reported a position in Starling Oncology in Q4 2022 and has held it in 2 quarters since.
  • Jefferies Financial Group's Starling Oncology position peaked at $318K in Q4 2022.
  • 37 funds tracked by Wall St. Rank held Starling Oncology as of Q3 2026.

Based on Jefferies Financial Group's 13F filing for Q3 2026, filed 5 Nov 2026.